On April 3, 2026, Biote Corp. (NASDAQ: BTMD) announced the posting of its latest Investor Presentation on its website, which outlines the company's growth strategies and financial outlook for the upcoming fiscal year. The presentation, dated April 2026, is available in the Investor Relations section of Biote's website. The company reported a revenue of $192.2 million for the fiscal year ended December 31, 2025, with an adjusted EBITDA of $53.5 million, reflecting a margin of 27.8%. Biote's leadership emphasized their commitment to expanding their market presence and enhancing operational efficiencies through strategic initiatives. The presentation also highlighted the company's focus on hormone optimization and the growing demand for therapeutic wellness solutions. Biote aims to leverage its proprietary technology and training platform to increase the adoption of its services among healthcare practitioners. The company is optimistic about its growth trajectory, projecting revenues to exceed $190 million in 2026, with an adjusted EBITDA expected to surpass $38 million. This positive outlook is supported by the increasing market interest in personalized health and wellness solutions, positioning Biote as a leader in the industry. The information provided in the presentation is not deemed 'filed' under the Securities Exchange Act of 1934, and it is intended for informational purposes only. Investors are encouraged to review the full presentation for detailed insights into Biote's operational strategies and financial performance.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.